HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,732 | -12.4% | 19,158 | -1.3% | 0.00% | – |
| Q2 2023 | $22,523 | -28.9% | 19,417 | -7.5% | 0.00% | – |
| Q1 2023 | $31,690 | -41.9% | 20,988 | -2.8% | 0.00% | – |
| Q4 2022 | $54,500 | -35.9% | 21,588 | +6.6% | 0.00% | – |
| Q3 2022 | $85,000 | +46.6% | 20,247 | -3.6% | 0.00% | – |
| Q2 2022 | $58,000 | -49.6% | 21,002 | +4.2% | 0.00% | – |
| Q1 2022 | $115,000 | -39.2% | 20,155 | -3.1% | 0.00% | – |
| Q4 2021 | $189,000 | -58.6% | 20,807 | -51.0% | 0.00% | -100.0% |
| Q3 2021 | $456,000 | -30.1% | 42,491 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +27.1% | 41,943 | +32.6% | 0.00% | 0.0% |
| Q1 2021 | $513,000 | +130.0% | 31,635 | +198.6% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | +77.0% | 10,596 | +24.7% | 0.00% | – |
| Q3 2020 | $126,000 | -1.6% | 8,495 | -2.6% | 0.00% | – |
| Q2 2020 | $128,000 | +456.5% | 8,718 | +343.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 1,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |